RESUMEN
BACKGROUND: Care homes have experienced a high number of coronavirus disease 2019 (COVID-19)-related deaths among residents since the onset of the pandemic. However, up to May 2020, there has been a lack of information about the extent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among residents and staff in care homes and limited testing in this setting. METHODS: Combined nose and throat swab testing for SARS-CoV-2 RNA was carried out in 2455 residents and staff across 37 care homes in the London Borough of Bromley across a 3-week period. Results were reported within 24 hours of sample delivery, and data were collected on the presence or absence of symptoms. RESULTS: Overall, the point prevalence of SARS-CoV-2 infection was 6.5%, with a higher rate in residents (9.0%) than in staff (4.7%). A key finding was the high proportion of asymptomatic infection detected in staff (69%) and residents (51%), with evidence of underdetection of symptoms by care home staff. CONCLUSIONS: The high proportion of asymptomatic infection combined with underdetection of symptoms by care home staff indicates that offering a test to all residents and staff in care homes with rapid reporting of results would assist accurate identification of infected individuals, facilitating prompt infection prevention and control action.
Asunto(s)
COVID-19/virología , Hogares para Ancianos/estadística & datos numéricos , ARN Viral/genética , SARS-CoV-2/genética , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Infecciones Asintomáticas/epidemiología , COVID-19/diagnóstico , COVID-19/epidemiología , Prueba de COVID-19/métodos , Femenino , Humanos , Londres/epidemiología , Masculino , Persona de Mediana Edad , Pandemias , Prevalencia , ARN Viral/aislamiento & purificación , SARS-CoV-2/aislamiento & purificación , Adulto JovenRESUMEN
OBJECTIVES: The aim of the work was to develop and implement an improved selective neonatal Bacille-Calmette-Guerin (BCG) vaccine program in which neonates are systematically assessed, and those identified as at "high risk of being exposed to tuberculosis" are given neonatal BCG. DESIGN: Service models used in other parts of the country were assessed and their limitations and difficulties were carefully considered. Possible service models for local use were then considered. A selective neonatal BCG program involving universal neonatal screening was implemented. SAMPLE: A program was implemented offering BCG to high-risk neonates. RESULTS: As has been the case with other health trusts, developing a new neonatal BCG service met with obstacles and hurdles. Means of overcoming some of the difficulties are presented. Preliminary findings regarding the service model, including neonatal BCG uptake rates, were positive. CONCLUSION: A successful neonatal BCG program was implemented.
Asunto(s)
Vacuna BCG , Enfermería Neonatal/organización & administración , Selección de Paciente , Tuberculosis/prevención & control , Humanos , Recién Nacido , Mycobacterium/inmunología , Tuberculosis/inmunología , Reino UnidoRESUMEN
Uptake of MMR vaccinations is as low as 60% in some parts of the UK. This poses a serious public health issue. This longitudinal study investigates parental decisions about MMR and single vaccinations. Parents (n=114) rated their perceptions of the benefits and risks of immunisation, and emotion-related variables; and were followed up to ask their final immunisation decision. Analyses demonstrated that parental decisions were explained by emotion-related variables, specifically anticipated responsibility and regret. It was concluded that parents' decisions about MMR are strongly influenced by the idea than harm that occurs as a result of deciding to immunise (commission) is less acceptable than harm that occurs as a result of deciding not to immunise (omission) (known as 'omission bias').